NVDA 186.64 ▲2.78%GOOGL 284.78 ▲0.78%MSFT 530.61 ▼0.99%AMD 449.04 ▲11.04%INTC 56.28 ▲7.71%TSMC 375.44 ▲6.33%AMZN 259.30 ▼0.35%META 610.15 ▲0.84%AAPL 342.37 ▼0.52%PLTR 160.38 ▲3.48%
Markets at last close

Policy

HRA lists latest updates on UK health research oversight

·1 min read

The Health Research Authority has updated its news and updates page with recent announcements on UK health research regulation, ethics and public involvement. Last updated on 6 Aug 2026, the page highlights items including innovative fridge-free vaccine clinical trial results, engagement with the AI Airlock, and responses to consultations on rare disease therapies, care quality assessment and UK human genomic data safeguards.

Recent entries also include updates on the PATHWAYS Trial, guidance on research involving children, an Ebola vaccine fast-track review and reflections on regulation as a driver of trust in innovation. On 29 May 2026, the HRA published its 2026-27 business plan focused on faster, simpler and trusted research in the UK, alongside a new two-year plan to support safe use of AI in UK health research.

Originally reported by hra.nhs.ukRead the source →
Related coverage